Takeda Pharmaceutical Company Limited
Purification of factor VIII subspecies
Last updated:
Abstract:
The present invention relates to a method for purifying a Factor VIII (FVIII) subspecies from a composition comprising FVIII, said method comprising an anion exchange chromatography step, a size exclusion chromatography step, and a concentration step. The invention also relates to a composition comprising a purified FVIII subspecies.
Status:
Grant
Type:
Utility
Filling date:
22 Jun 2018
Issue date:
12 Apr 2022